Definium Therapeutics, Inc. (DFTX)
NASDAQ: DFTX · Real-Time Price · USD
37.40
-0.20 (-0.53%)
At close: Oct 2, 2026, 4:00 PM EDT
37.34
-0.06 (-0.16%)
After-hours: Oct 2, 2026, 7:30 PM EDT
Definium Therapeutics Market Cap
Definium Therapeutics has a market cap or net worth of $5.03 billion as of October 2, 2026. Its market cap has increased by 435.65% in one year.
Market Cap
5.03B
Enterprise Value
3.98B
1-Year Change
435.65%
Ranking
Category
Stock Price
$37.40
ChartMarket Cap Chart
Since March 4, 2020, Definium Therapeutics's market cap has increased from $595.37M to $5.03B, an increase of 744.07%. That is a compound annual growth rate of 38.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 5.03B | 280.98% |
| Dec 31, 2025 | 1.32B | 158.44% |
| Dec 31, 2024 | 510.39M | 247.80% |
| Dec 29, 2023 | 146.75M | 77.54% |
| Dec 30, 2022 | 82.66M | -85.99% |
| Dec 31, 2021 | 590.17M | -82.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oruka Therapeutics | 5.60B |
| Mirum Pharmaceuticals | 5.38B |
| Cogent Biosciences | 5.38B |
| Travere Therapeutics | 5.37B |
| CRISPR Therapeutics AG | 5.36B |
| PTC Therapeutics | 5.30B |
| Erasca | 5.16B |
| Dianthus Therapeutics | 4.93B |